MiMedx Group Inc reports results for the quarter ended June 30 - Earnings Summary

• MiMedx Group Inc MDXG.OQ reported quarterly adjusted earnings of 10 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 12 cents. The mean expectation of five analysts for the quarter was for earnings of 5 cents per share. Wall Street expected results to range from 5 cents to 6 cents per share.

• Revenue rose 13.1% to $98.61 million from a year ago; analysts expected $90.62 million.

• MiMedx Group Inc's reported EPS for the quarter was 6 cents​.

• The company reported quarterly net income of $9.62 million.

• MiMedx Group Inc shares had risen by 9.2% this quarter and lost 30.7% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 13.6% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for MiMedx Group Inc is $12.00, about 44.4% above its last closing price of $6.67

This summary was machine generated from LSEG data July 30 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)